Trastuzumab was also labelled with 225Ac and studied in a breast cancer spheroids model in vitro [91] and with 211At in athymic rat model with implanted MCF-7/HER2-18 breast carcinoma cells, in which the median survival almost doubled [92]. The gene discussed is ERBB2; the disease is breast carcinoma.